Skip to Content
  • Revenues ($M)
    $5,738
  • Revenue Percent Change
    5.1%
  • Profits ($M)
    $387
  • Profits Percent Change
    8.6%
  • Assets ($M)
    $3,926
  • Employees
    36,100
  • Market Value — as of March 31, 2016 ($M)
    $7,780
  • Previous Rank
    476
  • Morning Consult Brand Index
    C+

The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Ari Bousbib
Sector
Health Care
Industry
Health Care: Pharmacy and Other Services
HQ Location
Durham, NC
Websitehttp://www.quintilesims.com
Years on Fortune 500 List3
Employees36,100
Acquired IMS Health Holdings and changed name from Quintiles Transnational Holdings.

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$5,7385.1%
Profits ($M)$3878.6%
Assets ($M)$3,926-
Total Stockholder Equity ($M)$-564-
Market Value — as of March 31, 2016 ($M)$7,780-

Profit Ratios

Profit as % of Revenues6.7%
Profits as % of Assets9.9%
Profits as % of Stockholder Equity-

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.08
EPS % Change (from 2014)13.2%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2015)16.6%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-